文献速递腹部技术与安全CT

CT影像组学DNN模型可预警胰腺病灶EUS-FNA非诊断性穿刺

Avoid non-diagnostic EUS-FNA: a DNN model as a possible gatekeeper to distinguish pancreatic lesions prone to inconclusive biopsy.
PubMed 文献 · Br J Radiol · 2023-05-31

该研究回顾性纳入498例接受EUS-FNA的胰腺病灶患者,其中开发队列147例PDAC、验证队列37例PDAC,利用增强CT影像组学结合深度神经网络构建模型,区分易出现非诊断性EUS-FNA的PDAC病灶。开发队列AUC为0.821(95%CI 0.742-0.900),验证队列AUC为0.745(95%CI 0.534-0.956),模型优于传统病灶特征逻辑回归模型,可作为术前辅助工具提示内镜医师减少不必要的EUS-FNA。

要点

  • 增强CT影像组学DNN模型可在术前预警PDAC病灶EUS-FNA非诊断性风险。
  • 验证队列AUC为0.745,风险阈值0.60时净获益21.6%。
  • 模型解释性显示GLCM特征平均贡献最大,一阶特征总归因最重要。

核心结论

  • 基于增强CT影像组学的DNN模型有助于区分易出现非诊断性EUS-FNA的胰腺病灶,为内镜医师提供术前预警以减少不必要穿刺。

研究设计与样本

  • 回顾性研究,共纳入498例接受胰腺EUS-FNA的患者,开发队列含147例PDAC,验证队列含37例PDAC,非PDAC胰腺病灶亦进行探索性测试。
  • 影像组学特征从增强CT提取,降维后整合入深度神经网络(DNN),采用ROC曲线和决策曲线分析(DCA)评估模型,并以积分梯度分析模型可解释性。

诊断标准与关键数值

  • DNN模型区分易非诊断性EUS-FNA的PDAC病灶:开发队列AUC=0.821(95%CI 0.742-0.900),验证队列AUC=0.745(95%CI 0.534-0.956)。
  • 在所有队列中,DNN模型均优于基于传统病灶特征的逻辑回归模型,NRI>0(p<0.05)。
  • 验证队列在风险阈值0.60时,DNN模型净获益为21.6%。

临床应用与阅片要点

  • 对拟行EUS-FNA的胰腺病灶,可术前用增强CT影像组学DNN模型评估非诊断性穿刺风险,高风险者提示内镜医师调整策略。
  • 模型可解释性提示GLCM纹理特征平均贡献最大,一阶特征总归因最重要,阅片时可关注相应纹理改变。

局限性

  • 研究为回顾性设计,验证队列PDAC样本量较小(37例),结论需前瞻性多中心验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This work aimed to explore the utility of CT radiomics with machine learning for distinguishing the pancreatic lesions prone to non-diagnostic ultrasound-guided fine-needle aspiration (EUS-FNA).

METHODS: 498 patients with pancreatic EUS-FNA were retrospectively reviewed [Development cohort: 147 pancreatic ductal adenocarcinoma (PDAC); Validation cohort: 37 PDAC]. Pancreatic lesions not PDAC were also tested exploratively. Radiomics extracted from contrast-enhanced CT was integrated with deep neural networks (DNN) after dimension reduction. The receiver operating characteristic (ROC) curve, and decision curve analysis (DCA) were performed for model evaluation. And, the explainability of the DNN model was analyzed by integrated gradients.

RESULTS: The DNN model was effective in distinguishing PDAC lesions prone to non-diagnostic EUS-FNA (Development cohort: AUC = 0.821, 95% CI: 0.742-0.900; Validation cohort: AUC = 0.745, 95% CI: 0.534-0.956). In all cohorts, the DNN model showed better utility than the logistic model based on traditional lesion characteristics with NRI >0 (p < 0.05). And, the DNN model had net benefits of 21.6% at the risk threshold of 0.60 in the validation cohort. As for the model explainability, gray-level co-occurrence matrix (GLCM) features contributed the most averagely and the first-order features were the most important in the sum attribution.

CONCLUSION: The CT radiomics-based DNN model can be a useful auxiliary tool for distinguishing the pancreatic lesions prone to nondiagnostic EUS-FNA and provide alerts for endoscopists preoperatively to reduce unnecessary EUS-FNA.

ADVANCES IN KNOWLEDGE: This is the first investigation into the utility of CT radiomics-based machine learning in avoiding non-diagnostic EUS-FNA for patients with pancreatic masses and providing potential pre-operative assistance for endoscopists.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Qu, Yang, Li, et al. Avoid non-diagnostic EUS-FNA: a DNN model as a possible gatekeeper to distinguish pancreatic lesions prone to inconclusive biopsy. Br J Radiol. 2023. PMID: 37195026. doi:10.1259/bjr.20221112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。